Encoding a subunit of the N-methyl D-aspartate receptor, GRIN2D is highly expressed in hepatocellular cancer and can exert an obstacle effect on the immune response, thus promoting tumor growth [44]. Here, GRIN2D is linked to hepatocellular carcinoma.